WO2000049414A1 - Cause, in vitro determination and eradication of cancer - Google Patents
Cause, in vitro determination and eradication of cancer Download PDFInfo
- Publication number
- WO2000049414A1 WO2000049414A1 PCT/CZ1999/000009 CZ9900009W WO0049414A1 WO 2000049414 A1 WO2000049414 A1 WO 2000049414A1 CZ 9900009 W CZ9900009 W CZ 9900009W WO 0049414 A1 WO0049414 A1 WO 0049414A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- stuff
- stuff compound
- compound
- blood
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Definitions
- This invention applies to origin and way of extracorporeal identification of malignant and other disorder of human organism based on blood ions and to a stuff compound as blood stimulant.
- the up to now knowledge and identification techniques are not capable to detect the so called ..carcinogenic mood of organism" at the stage, when malignant proliferation does not exceed the level of separate cell groups affection yet and it does not appear in a macroscopic range.
- Psychic stress as a whole organism mobilizer plays main role of initiation mechanism.
- the area of Saley strain which is represented by limbic system with an axis hypothalamus - adrenal - thymus, when adrenaline egested to blood circulation influences the level of ions Na+, K+, Ca+ and by irritation of adrenal cortex even the level of glucocorticoids.
- the nerve impulse - stress By activation of mineral-corticoids and of human chorio-gonadotropine (HCG) the nerve impulse - stress at the same time transmits ions Na+ to each individual cell not only by vegetative nerve system, but also by omnipresent blood, which acts as general neurotransmitter.
- HCG human chorio-gonadotropine
- the impulse transmission influences the blood ion concentration levels of sodium (Na+), potassium (K+) and calcium (Ca+), which are substantial for an impulse - stress transmission to each individual cell in organism, especially to cells of immune system.
- the cells change remarkably electric potential of their cell membranes from previous state, including influence behavior of receptors - their shifting in for antigens, or possibly their shifting out depending on the membranes' electric potential level.
- inhospitable intracellular conditions arise when intracellular organelles are influenced.
- These cellular changes can generate an activation of mutagenous herpetic EB viruses, which have in 80% the same chain sequence as immunosuppressive interleucine 10 (IL-10).
- IL-10 immunosuppressive interleucine 10
- EBV is immunosuppressive as like as IL-10, so that it suppresses the immune system as regards to a malignant disease. 95% of world population is EBV positive and so only slight activation of this virus is sufficient for initiation of immunosuppression.
- People having antibodies against this virus or who experienced mononucleosis have antibodies against EB virus as well as against interleucinelO (IL-10) immunosuppressor itself, so they cannot contract a cancer.
- IL-10 immunosuppressive interleucine 10
- T-lymphocytes In cooperation with HCG and thyme function suppression, when misactivation of T-lymphocytes occurs, which interrupt to produce interleucine 3 (IL-3), which does not activate macrofages and T-helpers' lymphocytes, on the contrary the Ts suppressor lymphocytes, which suppress the immune system, become active.
- IL-3 interleucine 3
- Ts suppressor lymphocytes which suppress the immune system.
- multiplied cell colonies continue in immunosuppressivity through their metabolites like alpha 1 phetoprotein at simultaneous suppression of human chorio-gonadotropine (HCG) influence.
- HCG human chorio-gonadotropine
- the subject is as well an elucidation, that in case of extremely positive reaction to stress there appears an allergic disease and that extremely negative reaction to stress could initiate malignant proliferation.
- the subject is as well a way of extracorporeal identification of malignant proliferation and other illnesses, which is convenient mainly for identification of cancer in human organism.
- ion concentration levels of sodium (Na+), potassium (K+) and calcium (Ca+) the relative ratio of which determines the level of these ions in intracellular space simultaneously.
- stress constant Cs V Na / V ⁇ , where
- Csp 36.
- Carcinogenic constant lower value (Ccl) 12,0 [(mmol/l) "1 ],
- Carcinogenic constant upper value (Ccu) 13,2 [(mmol/l) "1 ].
- Nerve-impulses are transmitted in vegetative and somatic nervous systems by sodium ions. Cells are nourished with the help of adenosine-triphosfate pump. It means, that nerve-impulse is not transmitted to cell by vegetative nerves only, but with the help of blood as well. The blood contains also ions, which thanks to their mutual concentrations transfer this impulse. In reality it means prolongation of Saley strain.
- blood acts as general purpose and omnipresent neurotransmitter. So that nerve-impulses are transmitted by nerve system and blood as well. In such case we can distinguish short time impulses of high intensity - vegetative ones and long time impulses of lower intensity - transferred by blood. Stress acts to the immune system by oscillations created due to chaotic principle of nerve and blood systems (see figure No. 1 ). Stress is transmitted in organism by the help of sodium - potassium pump, so by ions, by nerves and blood.
- Cc carcinogenic constant
- a cell which is damaged by other way as well, can do nothing like to run away or to defend, and as does not exist a place to run away, a cell starts to multiply by EBV and initiates immunosuppression simultaneously.
- the base of malignant tumor liquidation consists of neurotransmitter implementation, which adjusts cell membrane potentials to initiate reverse effect and so to activate immune cells. Parallel to this a total modification of tissue rinsing environment is necessary, not to initiate a new reverse process. It is necessary to exclude cytostatics and so to prevent a later malignant disease attack due to destruction of immune cells.
- the proposed computer software enables from laboratory blood analysis of sodium (Na+), potassium (K+) and calcium (Ca+) ions to identify immediately the pathologic risk of organism by starting malignant proliferation or allergic disease. Further it calculates from the analysed values the masses of (Na+), (K+) and (Ca+) for the therapeutic stuff compound acting as blood stimulant.
- the invention priority is mainly the fact, that it enables to identify malignant proliferation even before the stage of clinical detection, that means even with a mass lower than 1 gram, which is not possible to reach by contemporary mechanismes. So it is possible to trace even malignantappelmood" of organism.
- Basic advantage is as well the extracorporeal identification of malignant disease.
- the proposed solution is very simple and commonly accessible, economically undemanding, very easy repeatable, standardized on all working places and thus comparable, it is possible to screen in very cheap way unlimited sample of people and to examine simultaneously the whole body even in risk stages of malignant proliferation.
- No. 1 figure shows in graphic way the course of stress oscillation changes during impulse transmission in blood and in vegetative nerve system and the influence of cell membrane electric potential by stress oscillations.
- No. 2 figure shows the evaluation of extracorporeal identification result in graphic way, mainly of human malignant disease, including the calculation of stated element ions for 100 g of stuff compound.
- No. 3 figure shows the table of calculation of the Na, K, Ca ion content in the stuff - RESTIMOSOL
- the illness has not to be quite apparent, but it could proceed latently, as spring fatigue or common fatigue, which could be associated only with light febriles or subfebriles, plainly said with unpalpable easy to overlook symptoms.
- the mentioned EBV is rigidly bound to cell so that it multiplies by geometric series as a virus.
- the stress constant Cs V Na / V ⁇ , where V Na and V ⁇ are ion contents in blood plasma in mmol/l.
- the multiplied cell need not necessary contain EBV, its multiplication is allowed by the presence of EBV as immunosuppressor of IL-12 and HCG and at the same time thyme suppression takes place, which does not activate T- lymphocytes. They cease the production of interleucin 3 (IL-3), so that a misactivation of macrofages and T-helpers' lymphocytes occur, but due to real danger Ts suppressor lymphocytes activate and continue in further suppression of the immune system - defence mechanismes.
- the malignant cell initiated in this way may continue its multiplication in environment of increased content of Na+, other signal transfer is not possible.
- compound ratios of therapeutic stuff compound were calculated under commercial name RESTIMOSOL (see figure No. 3) for the treatment of given condition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU28248/99A AU2824899A (en) | 1999-02-19 | 1999-03-29 | Cause, in vitro determination and eradication of cancer |
EP99908739A EP1163525A1 (en) | 1999-02-19 | 1999-03-29 | Cause, in vitro determination and eradication of cancer |
SK1376-2001A SK13762001A3 (en) | 1999-02-19 | 1999-03-29 | Cause, in vitro determination and eradication of cancer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ1999555A CZ9900555A3 (en) | 1999-02-19 | 1999-02-19 | Method of extracorporeal identification of malignant and another disease of humans and mixture of substances as blood stimulant |
CZPV555-99 | 1999-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000049414A1 true WO2000049414A1 (en) | 2000-08-24 |
Family
ID=5461898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CZ1999/000009 WO2000049414A1 (en) | 1999-02-19 | 1999-03-29 | Cause, in vitro determination and eradication of cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1163525A1 (en) |
AU (1) | AU2824899A (en) |
CZ (1) | CZ9900555A3 (en) |
SK (1) | SK13762001A3 (en) |
WO (1) | WO2000049414A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8999313B2 (en) | 2012-09-11 | 2015-04-07 | Norgine Bv | Compositions |
US9592252B2 (en) | 2011-03-11 | 2017-03-14 | Norgine Bv | Colonoscopy—preparation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
EP0596717A1 (en) * | 1992-11-05 | 1994-05-11 | Chandra Consultants | Nutritional supplement for the elderly |
RU2018833C1 (en) * | 1990-02-28 | 1994-08-30 | Ивановский научно-исследовательский институт материнства и детства | Method for forecasting tendency of adaptation process at schoolchildren by their returning from south sanatorium |
-
1999
- 1999-02-19 CZ CZ1999555A patent/CZ9900555A3/en unknown
- 1999-03-29 WO PCT/CZ1999/000009 patent/WO2000049414A1/en not_active Application Discontinuation
- 1999-03-29 AU AU28248/99A patent/AU2824899A/en not_active Abandoned
- 1999-03-29 SK SK1376-2001A patent/SK13762001A3/en unknown
- 1999-03-29 EP EP99908739A patent/EP1163525A1/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
RU2018833C1 (en) * | 1990-02-28 | 1994-08-30 | Ивановский научно-исследовательский институт материнства и детства | Method for forecasting tendency of adaptation process at schoolchildren by their returning from south sanatorium |
EP0596717A1 (en) * | 1992-11-05 | 1994-05-11 | Chandra Consultants | Nutritional supplement for the elderly |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9592252B2 (en) | 2011-03-11 | 2017-03-14 | Norgine Bv | Colonoscopy—preparation |
US10646512B2 (en) | 2011-03-11 | 2020-05-12 | Norgine Bv | Colonoscopy - preparation |
US10780112B2 (en) | 2011-03-11 | 2020-09-22 | Norgine Bv | Colonoscopy-preparation |
US10792306B2 (en) | 2011-03-11 | 2020-10-06 | Norgine Bv | Colonoscopy—preparation |
US11529368B2 (en) | 2011-03-11 | 2022-12-20 | Norgine Bv | Colonoscopy—preparation |
US8999313B2 (en) | 2012-09-11 | 2015-04-07 | Norgine Bv | Compositions |
US9326969B2 (en) | 2012-09-11 | 2016-05-03 | Norgine Bv | Compositions |
US10016504B2 (en) | 2012-09-11 | 2018-07-10 | Norgine Bv | Compositions |
US10918723B2 (en) | 2012-09-11 | 2021-02-16 | Norgine Bv | Colon cleansing compositions and methods of use |
US12083179B2 (en) | 2012-09-11 | 2024-09-10 | Norgine Bv | Colon cleansing compositions and method of use |
Also Published As
Publication number | Publication date |
---|---|
CZ9900555A3 (en) | 2000-10-11 |
AU2824899A (en) | 2000-09-04 |
SK13762001A3 (en) | 2003-09-11 |
EP1163525A1 (en) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Takata et al. | Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection | |
Goodkin et al. | Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men | |
Ananworanich et al. | A novel acute HIV infection staging system based on 4 th generation immunoassay | |
Vatnikov et al. | Immune-inflammatory concept of the pathogenesis of chronic heart failure in dogs with dilated cardiomyopathy | |
Tree et al. | A mini meta‐analysis of studies on CD4+ CD25+ T cells in human type 1 diabetes: report of the Immunology of Diabetes Society T Cell Workshop | |
Vadrevu et al. | Frontline science: plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy | |
Rowin et al. | Granulocyte macrophage colony‐stimulating factor treatment of a patient in myasthenic crisis: Effects on regulatory T cells | |
Sanders et al. | The D uke myasthenia gravis clinic registry: I. D escription and demographics | |
Lee et al. | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib | |
CN106916217A (en) | Using the method for iTRAQ technical research Chronic Infection of Toxoplasma Mice brain tissues differential expression protein groups | |
Olff et al. | Modulatory effects of defense and coping on stress-induced changes in endocrine and immune parameters | |
Ansari et al. | Managing thalassemia in the developing world: an evidence-based approach for prevention, transfusion independency, and curative treatment with hematopoietic stem cell transplantation | |
WO2010045611A2 (en) | Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases | |
Klam et al. | Vestibular signals of posterior parietal cortex neurons during active and passive head movements in macaque monkeys | |
Zhou et al. | The proportion of CD19+ CD24hiCD27+ regulatory B cells predicts the occurrence of acute allograft rejection in liver transplantation | |
Patavino et al. | Number of recent sexual partners among blood donors in Brazil: associations with donor demographics, donation characteristics, and infectious disease markers | |
Wyles et al. | The albumin immunological and Nei electrophoretic distance correlation: a calibration for the saurian genus Anolis (Iguanidae) | |
WO2000049414A1 (en) | Cause, in vitro determination and eradication of cancer | |
Thomas et al. | Uptake of [14C] aspartic acid and [14C] glutamic acid by retinal synaptosomal fractions | |
Omoregie et al. | Prevalence of antibodies to HAART agents among HIV patients in Benin City, Nigeria | |
Liang et al. | Influence of combination antiretroviral therapy on HIV-1 serological responses and their implications: a systematic review and meta-analysis | |
BEAN et al. | Selective inhibition of flagellar activity in Chlamydomonas by nickel | |
Davidson et al. | MAO inhibition and control of anxiety following amitriptyline therapy: a pilot study | |
Costaggiu et al. | A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients | |
McGarvey | Biocultural predictors of age increases in adult blood pressure among Samoans |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BG BR CA CN EE HU IL JP LT MX NZ PL SK TR UA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999908739 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13762001 Country of ref document: SK |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1999908739 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999908739 Country of ref document: EP |